zealand_logo_RGB_01.png
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results
February 20, 2024 02:00 ET | Zealand Pharma
Press Release – No. 2 / 2024 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financial results Copenhagen, Denmark, February 20, 2024 – a Zealand...
zealand_logo_RGB_01.png
Total number of shares and voting rights in Zealand Pharma at January 31, 2024
January 31, 2024 11:00 ET | Zealand Pharma
Company announcement – No. 7 / 2024 Total number of shares and voting rights in Zealand Pharma at January 31, 2024 Copenhagen, Denmark, January 31, 2024 – Zealand Pharma A/S (“Zealand”)...
zealand_logo_RGB_01.png
Zealand Pharma major shareholder announcement: Van Herk Investments
January 26, 2024 12:00 ET | Zealand Pharma
Company announcement – No. 6 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 26 January 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no....
zealand_logo_RGB_01.png
Zealand Pharma major shareholder announcement: J O Hambro Capital Management
January 19, 2024 11:30 ET | Zealand Pharma
Company announcement – No. 5 / 2024 Zealand Pharma major shareholder announcement: J O Hambro Capital Management Copenhagen, Denmark, 19 January 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL)...
zealand_logo_RGB_01.png
Zealand Pharma major shareholder announcement: J O Hambro Capital Management
January 17, 2024 10:30 ET | Zealand Pharma
Company announcement – No. 4 / 2024 Zealand Pharma major shareholder announcement: J O Hambro Capital Management Copenhagen, Denmark, 17 January 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq:...
zealand_logo_RGB_01.png
Zealand Pharma completes registration of capital increase
January 12, 2024 05:00 ET | Zealand Pharma
Company announcement – No. 3 / 2024 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES,...
zealand_logo_RGB_01.png
Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC
January 10, 2024 11:15 ET | Zealand Pharma
Company announcement – No. 2 / 2024 Zealand Pharma major shareholder announcement: Avoro Capital Advisors LLC Copenhagen, Denmark, 10 January 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq:...
zealand_logo_RGB_01.png
Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion
January 08, 2024 15:45 ET | Zealand Pharma
Company announcement – No. 1 / 2024 Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN...
zealand_logo_RGB_01.png
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th
January 02, 2024 02:00 ET | Zealand Pharma
Press Release – No. 1 / 2024 Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on January 4th Copenhagen, Denmark, January 2, 2024 – Zealand...
zealand_logo_RGB_01.png
Total number of shares and voting rights in Zealand Pharma at December 29, 2023
December 29, 2023 11:00 ET | Zealand Pharma
Company announcement – No. 46 / 2023 Total number of shares and voting rights in Zealand Pharma at December 29, 2023 Copenhagen, Denmark, December 29, 2023 – Zealand Pharma A/S (“Zealand”)...